Previous 10 | Next 10 |
NovaBay Pharmaceuticals' (NYSEMKT: NBY ) Avenova Direct is now available at affordable pricing and without a prescription on Amazon.com through the Company’s new direct-to-consumer online channel. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stock...
Original formulation of Avenova ® for the management of bacterial dry eye is now available at an affordable price without a prescription NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for ...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces that on May 16, 2019 it received notice (the “Notice”) from the NYSE American LLC that ...
NovaBay Pharmaceuticals, Inc (NBY) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Bruce Voss - Investor Relations, LHA Justin Hall - Interim President & Chief Executive Officer Jason Raleigh - Interim Chief Financial Officer Conference Call P...
NovaBay (NYSEMKT: NBY ): Q1 GAAP EPS of -$0.28 misses by $0.15 . Revenue of $1.5M (-49.2% Y/Y) misses by $0.59M . Shares +10.5% . Press Release More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,
Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three mon...
Management to discuss new partner pharmacy program and expanded access to in-office direct channel NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, an...
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces that it will hold a virtual Annual Meeting of Stockholders on Thursday, May 30, 2019 at 5:00 p.m. Pac...
Affirms long-term commitment to make Avenova convenient for both eye care specialists and patients NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company, announces a new pharmacy partnering program in a continued effort to ensure all patients in the...
Gainers: AVEO Pharmaceuticals (NASDAQ: AVEO ) +35% . ADMA Biologics (NASDAQ: ADMA ) +32% . Sangamo Therapeutics (NASDAQ: SGMO ) +27% . Castor Maritime (NASDAQ: CTRM ) +24% . EDAP TMS S.A. (NASDAQ: EDAP ) +23% . Riot Blockchain (NASDAQ: RIOT ) +22% . Vaccinex (NASDAQ: VCNX ) +1...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...